Skip to main content

ProShares Trust II

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

SCO$20.19+2.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

ProShares UltraShort Euro

December 31, 2024December 31, 2023
Assets
Cash$36,236,198$34,758,230
Segregated cash balances with brokers for foreign currency forward contracts4,402,1126,332,112
Unrealized appreciation on foreign currency forward contracts1,189,82738,029
Interest receivable129,971159,359
Total assets41,958,10841,287,730
Liabilities and shareholders’ equity
Liabilities
Payable to Sponsor32,65733,372
Unrealized depreciation on foreign currency forward contracts32,7771,886,808
Total liabilities65,4341,920,180
Commitments and Contingencies (Note 2)
Shareholders’ equity
Shareholders’ equity41,892,67439,367,550
Total liabilities and shareholders’ equity$41,958,108$41,287,730
Shares outstanding1,200,0001,350,000
Net asset value per share$34.91$29.16
Market value per share (Note 2)$34.92$29.15

^

Settlement DateContract Amount in Local CurrencyContract Amount in U.S. DollarsUnrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Euro with UBS AG01/10/253,395,000$3,518,153$(32,777)
Total Unrealized Depreciation$(32,777)
Contracts to Sell
Euro with Goldman Sachs International01/10/25(38,554,263)$(39,952,817)$584,165
Euro with UBS AG01/10/25(45,657,199)(47,313,413)605,662
Total Unrealized Appreciation$1,189,827
^The positions and counterparties herein are as of December 31, 2024. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.

^

Settlement DateContract Amount in Local CurrencyContract Amount in U.S. DollarsUnrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Euro with Goldman Sachs International01/19/245,315,000$5,872,288$27,910
Euro with UBS AG01/19/243,395,0003,750,97210,119
Total Unrealized Appreciation$38,029
Contracts to Sell
Euro with Goldman Sachs International01/19/24(41,248,263)$(45,573,223)$(992,052)
Euro with UBS AG01/19/24(38,689,199)(42,745,837)(894,756)
Total Unrealized Depreciation$(1,886,808)
^The positions and counterparties herein are as of December 31, 2023. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.
Year Ended December 31,
202420232022
Investment Income
Interest$1,650,526$2,251,539$906,928
Expenses
Management fee360,078505,085676,052
Non-recurring fees and expenses——3,838
Total expenses360,078505,085679,890
Net investment income (loss)1,290,4481,746,454227,038
Realized and unrealized gain (loss) on investment activity
Net realized gain (loss) on
Foreign currency forward contracts2,509,965(2,624,737)6,792,065
Short-term U.S. government and agency obligations4,641—210,974
Net realized gain (loss)2,514,606(2,624,737)7,003,039
Change in net unrealized appreciation (depreciation) on
Foreign currency forward contracts3,005,829612,477(2,253,215)
Short-term U.S. government and agency obligations—(4,802)11,965
Change in net unrealized appreciation (depreciation)3,005,829607,675(2,241,250)
Net realized and unrealized gain (loss)5,520,435(2,017,062)4,761,789
Net income (loss)$6,810,883$(270,608)$4,988,827
Year Ended December 31,
202420232022
Shareholders’ equity, beginning of period$39,367,550$75,113,179$54,263,045
Addition of 250,000, 300,000 and 2,200,000 shares, respectively8,047,6109,033,52070,696,876
Redemption of 400,000, 1,500,000 and 1,750,000 shares, respectively(12,333,369)(44,508,541)(54,835,569)
Net addition (redemption) of (150,000), (1,200,000) and 450,000 shares, respectively(4,285,759)(35,475,021)15,861,307
Net investment income (loss)1,290,4481,746,454227,038
Net realized gain (loss)2,514,606(2,624,737)7,003,039
Change in net unrealized appreciation (depreciation)3,005,829607,675(2,241,250)
Net income (loss)6,810,883(270,608)4,988,827
Shareholders’ equity, end of period$41,892,674$39,367,550$75,113,179
Year Ended December 31,
202420232022
Cash flow from operating activities
Net income (loss)$6,810,883$(270,608)$4,988,827
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Purchases of short-term U.S. government and agency obligations—(54,925,175)(274,581,000)
Proceeds from sales or maturities of short-term U.S. government and agency obligations4,64195,000,000282,210,974
Net amortization and accretion on short-term U.S. government and agency obligations—(83,003)(442,534)
Net realized (gain) loss on investments(4,641)—(210,974)
Change in unrealized (appreciation) depreciation on investments(3,005,829)(607,675)2,241,250
Decrease (Increase) in interest receivable29,388(49,529)(109,227)
Increase (Decrease) in payable to Sponsor(715)(30,003)18,668
Net cash provided by (used in) operating activities3,833,72739,034,00714,115,984
Cash flow from financing activities
Proceeds from addition of shares8,047,6109,033,52070,696,876
Payment on shares redeemed(12,333,369)(44,508,541)(54,835,569)
Net cash provided by (used in) financing activities(4,285,759)(35,475,021)15,861,307
Net increase (decrease) in cash(452,032)3,558,98629,977,291
Cash, beginning of period41,090,34237,531,3567,554,065
Cash, end of period$40,638,310$41,090,342$37,531,356
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.